Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.
(Q39943645)
scientific article published on 12 January 2010
scientific article published on 12 January 2010
Language:
Current Data About
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.